{"id":2397,"date":"2015-07-31T19:00:35","date_gmt":"2015-07-31T19:00:35","guid":{"rendered":"https:\/\/www.lymphoma.ca\/congres-de-lassociation-europeenne-dhematologie-2015\/"},"modified":"2022-01-16T02:35:29","modified_gmt":"2022-01-16T02:35:29","slug":"congres-de-lassociation-europeenne-dhematologie-2015","status":"publish","type":"post","link":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/","title":{"rendered":"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie  2015"},"content":{"rendered":"<p>Le 20e congr\u00e8s annuel de l\u2019Association europ\u00e9enne d\u2019h\u00e9matologie s\u2019est tenu \u00e0 Vienne du 11 au 14 juin 2015. Il a fourni aux participants un forum leur permettant de pr\u00e9senter<br \/>\n<!--more--><\/p>\n<p>Le 20e congr\u00e8s annuel de l\u2019Association europ\u00e9enne d\u2019h\u00e9matologie s\u2019est tenu \u00e0 Vienne du 11 au 14 juin 2015. Il a fourni aux participants un forum leur permettant de pr\u00e9senter des donn\u00e9es originales encore in\u00e9dites, de partager des id\u00e9es sur l\u2019innovation en h\u00e9matologie, ainsi que de\u00a0 r\u00e9pandre des connaissances bas\u00e9es sur des donn\u00e9es probantes, dont la pertinence clinique s\u2019av\u00e8re de premi\u00e8re importance. Les participants au congr\u00e8s de cette ann\u00e9e, essentiellement des h\u00e9matologues et des professionnels affili\u00e9s ont pu\u00a0:<\/p>\n<ul>\n<li>\u00e9largir leurs connaissances des approches bas\u00e9es sur des donn\u00e9es valid\u00e9es par des preuves scientifiques, portant sur le diagnostic et le traitement des maladies du sang<\/li>\n<li>acc\u00e9der aux plus r\u00e9cents r\u00e9sultats des recherches cliniques et translationnelles \u00a0portant sur les maladies du sang<\/li>\n<li>se mettre \u00e0 jour en ce qui concerne les techniques innovatrices \u00a0qui font leur apparition, les outils de diagnostic et les strat\u00e9gies d\u2019\u00e9valuation des risques en h\u00e9matologie et dans les sous-sp\u00e9cialit\u00e9s<\/li>\n<li>se constituer un r\u00e9seau de repr\u00e9sentants d\u2019un vaste public \u00a0international avec qui ils ont pu \u00a0communiquer et collaborer\u00a0: professionnels de la sant\u00e9, soci\u00e9t\u00e9s nationales d\u2019h\u00e9matologie , groupes de patient, industrie m\u00e9dicale et m\u00e9dia.<\/li>\n<\/ul>\n<div>\n<p><strong>Faits saillants du congr\u00e8s de l\u2019A.E.H, tells que fournis par<\/strong>\u00a0<a href=\"http:\/\/fusehealth.ca\/\" target=\"_blank\" rel=\"noopener noreferrer\">Fuse Health<\/a>.<\/p>\n<\/div>\n<p>&nbsp;<\/p>\n<h2>Faits saillants du congr\u00e8s<\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" size-full wp-image-2341\" title=\"TYK2 PATHWAY \" src=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/the_tyk2_pathway_as_a_novel_therapeutic_intervention_site_in_aggressive_t-cell_lymphoma.jpeg\" alt=\"TYK2 PATHWAY \" width=\"250\" height=\"188\" srcset=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/the_tyk2_pathway_as_a_novel_therapeutic_intervention_site_in_aggressive_t-cell_lymphoma.jpeg 1024w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/the_tyk2_pathway_as_a_novel_therapeutic_intervention_site_in_aggressive_t-cell_lymphoma-300x225.jpeg 300w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/the_tyk2_pathway_as_a_novel_therapeutic_intervention_site_in_aggressive_t-cell_lymphoma-768x576.jpeg 768w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/p>\n<p>Nouvelles de derni\u00e8re heure\u00a0 qui ont retenu l\u2019attention au congr\u00e8s de l\u2019AEH en 2015<\/p>\n<p>LE PARCOURS TYK2 , NOUVEAU SITE D\u2019 INTERVENTION TH\u00c9RAPEUTIQUE POUR LE LYMPHOME \u00c0 CELLULES-T AGRESSIF<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" size-full wp-image-2343\" title=\"prIME Oncology in Relapsed Refractory Multiple Myeloma\" src=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/prime_oncology_in_relapsed_refractory_multiple_myeloma.jpeg\" alt=\"prIME Oncology in Relapsed Refractory Multiple Myeloma\" width=\"250\" height=\"188\" srcset=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/prime_oncology_in_relapsed_refractory_multiple_myeloma.jpeg 1024w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/prime_oncology_in_relapsed_refractory_multiple_myeloma-300x225.jpeg 300w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/prime_oncology_in_relapsed_refractory_multiple_myeloma-768x576.jpeg 768w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/p>\n<p>Symposium bien structur\u00e9: \u2018\u2019 \u00a0prIME Oncology in Relapsed Refractory Multiple Myeloma: Embracing the Person in Personalized Care\u2019\u2019: il incluait un patient, Yelak Beru, comme\u00a0 intervenant, qui a exprim\u00e9 son point de vue \u00e0 chaque \u00e9tape de la pr\u00e9sentation clinique.\u00a0 Il a ainsi hiss\u00e9 la barre \u00e0 un niveau international en ce qui concerne la d\u00e9fense des patients.\u00a0 Une des recommandations de M. Beru aux m\u00e9decins, \u00ab\u00a0\u00c9duquez-nous, nous, vos \u00a0patients, par le biais des m\u00e9dias sociaux. Nous appr\u00e9cions beaucoup que vous nous fassiez passer l\u2019information.\u00a0\u00bb\u00a0Il a peut-\u00eatre convaincu Dr. Palumbo de commencer \u00e0 \u00a0twitter.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" size-full wp-image-2345\" title=\"PRIMARY RESULTS FROM A PHASE III STUDY OF OBINUTUZUMAB \" src=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/primary_results_from_a_phase_iii_study_of_obinutuzumab_plus_bendamustine.jpeg\" alt=\"PRIMARY RESULTS FROM A PHASE III STUDY OF OBINUTUZUMAB \" width=\"250\" height=\"188\" srcset=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/primary_results_from_a_phase_iii_study_of_obinutuzumab_plus_bendamustine.jpeg 1024w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/primary_results_from_a_phase_iii_study_of_obinutuzumab_plus_bendamustine-300x225.jpeg 300w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/primary_results_from_a_phase_iii_study_of_obinutuzumab_plus_bendamustine-768x576.jpeg 768w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/p>\n<p>Les participants canadiens \u00e0 l\u2019AEH.<\/p>\n<p>Laurie Sehn (Centre for Lymphoid Cancer BCCA) a partag\u00e9 les r\u00e9sultats d\u2019un r\u00e9sum\u00e9 de derni\u00e8re heure : GADOLIN: PREMIERS R\u00c9SULTATS D\u2019UNE RECHERCHE EN PHASE III SUR L\u2019OBINUTUZUMAB \u00a0PLUS BENDAMUSTINE, COMPAR\u00c9E \u00c0 LA BENDAMUSTINE \u00a0SEULE CHEZ DES PATIENTS ATTEINTS DE LYMPHOME\u00a0 NON-HODGKINIEN INDOLENT\u00a0 R\u00c9FRACTAIRE AU RITUXIMAB ( \u00a0PRIMARY RESULTS FROM A PHASE III STUDY OF OBINUTUZUMAB PLUS BENDAMUSTINE COMPARED WITH BENDAMUSTINE ALONE IN PATIENTS WITH RITUXIMAB-REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA)<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" size-full wp-image-2347\" title=\"the real life analysis from the The CML patient registry \" src=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/real_life_analysis_from_the_the_cml_patient_registry_of_cml-mpn_quebec.jpeg\" alt=\"the real life analysis from the The CML patient registry \" width=\"250\" height=\"207\" srcset=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/real_life_analysis_from_the_the_cml_patient_registry_of_cml-mpn_quebec.jpeg 504w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/real_life_analysis_from_the_the_cml_patient_registry_of_cml-mpn_quebec-300x248.jpeg 300w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/p>\n<p>UNE ANALYSE FAITE SUR UN CAS R\u00c9EL\u00a0 DE LA GESTION DU LMC (lymphome \u00e0 cellules du manteau) MONTRE QUE LA TH\u00c9RAPIE DE SECONDE LIGNE EST SOUVENT UTILIS\u00c9E MAIS INTERROMPUE PR\u00c9MATUR\u00c9MENT\u00a0 POUR CAUSE D\u2019INTOL\u00c9RANCE\u00a0: RAPPORT DU GROUPE QU\u00c9B\u00c9COIS DE RECHERCHE EN LMC-NMP<\/p>\n<p>Lambert Busque (H\u00e9matologue, Maisonneuve-Rosemont, Qu\u00e9bec) discute les conclusions de l\u2019analyse tir\u00e9e du registre des patients du LCM, Groupe de recherche du Qu\u00e9bec LMC-MPN \u00a0\u00a0(<a href=\"http:\/\/www.gqr-lmc-nmp.ca\/\">www.gqr-lmc-nmp.ca<\/a>).<\/p>\n<p>Rendez-vous en ligne sur le site <a href=\"https:\/\/ehaweb.org\/education\/ehacampus\/\">EHA Learning Centre<\/a> pour de plus amples renseignements sur les expos\u00e9s et les r\u00e9sum\u00e9s pr\u00e9sent\u00e9s au congr\u00e8s.<\/p>\n<p class=\"alignleft\"><span style=\"font-size: 15px;\"><img loading=\"lazy\" decoding=\"async\" class=\" size-full wp-image-2349\" title=\"Idelalisib+ ofatumumab - CLL\" src=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/cll_idelalisib.jpg\" alt=\"Idelalisib plus ofatumumab in CLL\" width=\"250\" height=\"200\" srcset=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/cll_idelalisib.jpg 1024w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/cll_idelalisib-300x240.jpg 300w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/cll_idelalisib-768x614.jpg 768w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/span><\/p>\n<p>Donn\u00e9es positives de l\u2019essai en \u00a0phase 3<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" size-full wp-image-2351\" style=\"font-size: 15px;\" title=\"Frail patients with DLBCL\" src=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/dlbcl.jpg\" alt=\"frail patients with DLBCL\" width=\"250\" height=\"171\" srcset=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/dlbcl.jpg 1024w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/dlbcl-300x206.jpg 300w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/dlbcl-768x527.jpg 768w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/p>\n<p>Nouvelles \u00a0options pour patients \u00e2g\u00e9s et fragiles, atteints de \u00a0DLBCL<\/p>\n<p><span style=\"font-size: 15px;\"><img loading=\"lazy\" decoding=\"async\" class=\" size-full wp-image-2353\" title=\"idelalisib + rituximab in CLL\" src=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/idelalisib_cll.jpg\" alt=\"idelalisib + rituximab in CLL\" width=\"250\" height=\"188\" srcset=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/idelalisib_cll.jpg 1024w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/idelalisib_cll-300x225.jpg 300w, https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/idelalisib_cll-768x576.jpg 768w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/span><\/p>\n<p>B\u00e9n\u00e9fices pour la qualit\u00e9 de vie avec \u00a0idelalisib + rituximab pour \u00a0la leuc\u00e9mie lympho\u00efde chronique (LLC)<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-size: 15px;\">\u00a0<\/span><\/p>\n<p><span style=\"font-size: 15px;\">\u00a0<\/span><\/p>\n<p class=\"alignleft\">\n","protected":false},"excerpt":{"rendered":"<p>Le 20e congr\u00e8s annuel de l\u2019Association europ\u00e9enne d\u2019h\u00e9matologie s\u2019est tenu \u00e0 Vienne du 11 au 14 juin 2015. Il a fourni aux participants un forum leur permettant de pr\u00e9senter<\/p>\n","protected":false},"author":1,"featured_media":2339,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10,17],"tags":[],"class_list":{"0":"post-2397","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nouvelles","8":"category-recherche"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015 - Lymphoma Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015 - Lymphoma Canada\" \/>\n<meta property=\"og:description\" content=\"Le 20e congr\u00e8s annuel de l\u2019Association europ\u00e9enne d\u2019h\u00e9matologie s\u2019est tenu \u00e0 Vienne du 11 au 14 juin 2015. Il a fourni aux participants un forum leur permettant de pr\u00e9senter\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/\" \/>\n<meta property=\"og:site_name\" content=\"Lymphoma Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LymphomaCanada\" \/>\n<meta property=\"article:published_time\" content=\"2015-07-31T19:00:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-16T02:35:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png\" \/>\n\t<meta property=\"og:image:width\" content=\"250\" \/>\n\t<meta property=\"og:image:height\" content=\"151\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:site\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\"},\"headline\":\"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015\",\"datePublished\":\"2015-07-31T19:00:35+00:00\",\"dateModified\":\"2022-01-16T02:35:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/\"},\"wordCount\":645,\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png\",\"articleSection\":[\"Nouvelles\",\"Recherche\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/\",\"name\":\"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015 - Lymphoma Canada\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png\",\"datePublished\":\"2015-07-31T19:00:35+00:00\",\"dateModified\":\"2022-01-16T02:35:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#primaryimage\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png\",\"width\":250,\"height\":151},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lymphoma.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"name\":\"Lymphoma Canada\",\"description\":\"Information. Help. Hope.\",\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\",\"name\":\"Lymphoma Canada\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"width\":343,\"height\":343,\"caption\":\"Lymphoma Canada\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LymphomaCanada\",\"https:\/\/x.com\/lymphomacanada\",\"https:\/\/www.linkedin.com\/company\/lymphoma-canada\/\",\"http:\/\/instagram.com\/lymphomacanada\",\"http:\/\/www.youtube.com\/user\/LymphomaTV\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015 - Lymphoma Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/","og_locale":"fr_FR","og_type":"article","og_title":"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015 - Lymphoma Canada","og_description":"Le 20e congr\u00e8s annuel de l\u2019Association europ\u00e9enne d\u2019h\u00e9matologie s\u2019est tenu \u00e0 Vienne du 11 au 14 juin 2015. Il a fourni aux participants un forum leur permettant de pr\u00e9senter","og_url":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/","og_site_name":"Lymphoma Canada","article_publisher":"https:\/\/www.facebook.com\/LymphomaCanada","article_published_time":"2015-07-31T19:00:35+00:00","article_modified_time":"2022-01-16T02:35:29+00:00","og_image":[{"width":250,"height":151,"url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@lymphomacanada","twitter_site":"@lymphomacanada","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#article","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/"},"author":{"name":"admin","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4"},"headline":"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015","datePublished":"2015-07-31T19:00:35+00:00","dateModified":"2022-01-16T02:35:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/"},"wordCount":645,"publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png","articleSection":["Nouvelles","Recherche"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/","url":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/","name":"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015 - Lymphoma Canada","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#primaryimage"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png","datePublished":"2015-07-31T19:00:35+00:00","dateModified":"2022-01-16T02:35:29+00:00","breadcrumb":{"@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#primaryimage","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2015\/06\/resizedimage250151-eha20-anniversary-viennargb-internettransp.png","width":250,"height":151},{"@type":"BreadcrumbList","@id":"https:\/\/www.lymphoma.ca\/fr\/congres-de-lassociation-europeenne-dhematologie-2015\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lymphoma.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Congr\u00e8s de l\u2019Association Europ\u00e9enne d\u2019H\u00e9matologie 2015"}]},{"@type":"WebSite","@id":"https:\/\/www.lymphoma.ca\/fr\/#website","url":"https:\/\/www.lymphoma.ca\/fr\/","name":"Lymphoma Canada","description":"Information. Help. Hope.","publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.lymphoma.ca\/fr\/#organization","name":"Lymphoma Canada","url":"https:\/\/www.lymphoma.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","width":343,"height":343,"caption":"Lymphoma Canada"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LymphomaCanada","https:\/\/x.com\/lymphomacanada","https:\/\/www.linkedin.com\/company\/lymphoma-canada\/","http:\/\/instagram.com\/lymphomacanada","http:\/\/www.youtube.com\/user\/LymphomaTV"]},{"@type":"Person","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/2397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/comments?post=2397"}],"version-history":[{"count":3,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/2397\/revisions"}],"predecessor-version":[{"id":11374,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/2397\/revisions\/11374"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media\/2339"}],"wp:attachment":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media?parent=2397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/categories?post=2397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/tags?post=2397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}